Increased hepatocyte growth factor levels over 2 years are associated with coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA)

Hepatocyte growth factor (HGF) is associated with subclinical and clinical atherosclerosis. However, the significance of change in HGF and development of atherosclerotic disease is unknown. In a large and diverse population-based cohort, we report that change in the biomarker HGF is an independent p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am Heart J
Hlavní autoři: Decker, Paul A., Larson, Nicholas B., Bell, Elizabeth J., Pankow, James S., Hanson, Naomi Q., Wassel, Christina L., Tsai, Michael Y., Bielinski, Suzette J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6581609/
https://ncbi.nlm.nih.gov/pubmed/31085382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2019.03.018
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky